Search results for "hypertrophy"

showing 5 items of 335 documents

Effects of different accentuated eccentric loads on acute neuromuscular, growth hormone, and blood lactate responses during a hypertrophic protocol.

2009

This study monitored acute neuromuscular responses and growth hormone (GH) and blood lactate (La) concentrations in the eccentric-concentric (ECC-CON) hypertrophic protocol by using various dynamic accentuated external resistance (DAER) loads in the bench press exercise. Male subjects (age = 32 +/- 4 years; n = 11) performed 4 sets of 10 repetitions with 2 minutes of recovery between the sets. The loads were 70, 80, 90, and 100% of 1 repetition maximum (RM) for the ECC phase, whereas 70% RM was constantly used for the CON phase. Electromyographic activity (EMG), ECC, CON, and isometric (ISOM) forces, serum GH and blood La, were measured at pre- and postloading. Significant reductions occurr…

AdultMalemedicine.medical_specialtygenetic structuresDeltoid curvePhysical Therapy Sports Therapy and RehabilitationIsometric exerciseElectromyographyBench pressMuscle hypertrophyInternal medicineStatistical significanceIsometric ContractionmedicineEccentricHumansOrthopedics and Sports MedicineMuscle SkeletalAnalysis of Variancemedicine.diagnostic_testAnthropometrybusiness.industryElectromyographyResistance TrainingGeneral MedicineEndocrinologyGrowth HormoneCardiologyLactatesAnalysis of variancebusinessJournal of strength and conditioning research
researchProduct

Treatment of masseteric hypertrophy with botulinum toxin: A report of two cases

2010

BAS, BURCU/0000-0003-0593-3400; Kutuk, Nukhet/0000-0001-6563-1899 WOS: 000279667400021 PubMed: 20173718 Masseter muscle hypertrophy is a rare condition of unknown cause which is important in the differential diagnosis of head and neck masses, located in the cheek. Several treatment options reported for masseter hypertrophy, which range from simple pharmacotherapy to more invasive surgical reduction. Botulinum toxin type A is a powerful neurotoxin which is produced by the anaerobic organism Clostridium botulinum and when injected into a muscle causes interference with the neurotransmitter mechanism producing selective paralysis and subsequent atrophy of the muscle. Injection of botulinum tox…

AdultMalemedicine.medical_specialtyNeurotoxinsmedicine.disease_causeMuscle hypertrophyMasseter muscleAtrophyParalysismedicineNeurotoxinHumansBotulinum Toxins Type AGeneral Dentistrybusiness.industryMasseter MuscleHypertrophyCheekmedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryMasseter musclebotulinum toxin type Amedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASClostridium botulinumSurgeryFemalemedicine.symptomDifferential diagnosisbusinesshypertrophy
researchProduct

Morbidity in 565 Type 2 Diabetic Patients According to Stage of Nephropathy

1998

Between 1988 and 1992, 565 type 2 diabetic patients were examined for nephropathy and diabetes-associated diseases during hospital treatment. Stages of nephropathy were defined as no clinical sign of nephropathy (N = 280), microalbuminuria (N = 38), overt proteinuria (N = 105), impaired renal function (N = 55), and chronic dialysis therapy (N = 87). In dialyzed patients, HbA1c averaged 6.8%, and, in the other groups, HbA1c was between 7.6% and 8.3% (normal range, 3.8%-6.1%). Cataract was not associated with the severity of nephropathy. Stroke was most common in the stage of renal insufficiency (34%). The following complications, as found in medical history or as current event, showed a sign…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMyocardial InfarctionBlood PressureGastroenterologyNephropathyCohort StudiesDiabetic nephropathyEndocrinologyRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineAlbuminuriaHumansCarotid StenosisDiabetic NephropathiesRenal replacement therapyAgedDiabetic RetinopathyProteinuriabusiness.industryMiddle Agedmedicine.diseaseSurgeryRenal Replacement TherapyCerebrovascular DisordersProteinuriaDiabetes Mellitus Type 2HypertensionAlbuminuriaFemaleHypertrophy Left VentricularMicroalbuminuriaMorbiditymedicine.symptombusinessKidney diseaseJournal of Diabetes and its Complications
researchProduct

Korelācija starp ehokardiogrammu un EKG atradni slimniekiem ar kreisā kambara hipertorfiju

2018

KOPSAVILKUMS Pamatojums Kreisā kambara hipertrofijai tiek pievērsta uzmanība globālā līmenī. Kreisā kambara hipertrofijas esamība un tās pakāpes novērtēšana ir neatņemama sastāvdaļa ikdienā veiktiem mērījumiem kardioloģijā. Gan ehokardiogrāfija (EhoKG), gan elektrokardiogrāfija (EKG) ir labi zināmas metodes kreisā kamabara hipertrofijas un ar to saistītā riska novērtēšanai. Kreisā kambara hipertrofija tiek uzskatīta par neatkarīgu kardiovaskulārās mirstības un saslimstības riska faktoru. Mērķis Noteikt kreisā kambara hipertrofijas pazīmes, izmantojot elektrokardiogrāfijas un ehokardiogrāfijas metodes, un noskaidrot korelāciju starp kreisā kambara hipertrofijas pazīmēm EKG un EhoKG, kā arī n…

IVSDEchocardiographyCorelationLeft ventricular hypertrophyMedicīnaElectrocardiogram
researchProduct

Effect of protein/essential amino acids and resistance training on skeletal muscle hypertrophy: A case for whey protein

2010

Regardless of age or gender, resistance training or provision of adequate amounts of dietary protein (PRO) or essential amino acids (EAA) can increase muscle protein synthesis (MPS) in healthy adults. Combined PRO or EAA ingestion proximal to resistance training, however, can augment the post-exercise MPS response and has been shown to elicit a greater anabolic effect than exercise plus carbohydrate. Unfortunately, chronic/adaptive response data comparing the effects of different protein sources is limited. A growing body of evidence does, however, suggest that dairy PRO, and whey in particular may: 1) stimulate the greatest rise in MPS, 2) result in greater muscle cross-sectional area when…

lihaskasvuvoimaharjoitteluproteiiniravintolisämuscle hypertrophyresistance trainingprotein supplementation
researchProduct